Skip to content
Editorial status
Listed · source-checked
Last reviewed
Mar 12, 2026
Next review due
Mar 12, 2027
Commercial relationship
Independent listing · no commercial relationship
Challenge window
Self-reported certifications labeled

CONTRACT MANUFACTURING

Gemini Pharmaceuticals

Gemini Pharmaceuticals has produced tablets, capsules, and OTC pharmaceuticals from Commack, New York for over 30 years. The company produces 13 billion dosage units per year and packages over 150,000 bottles per shift. They report FDA registration, Health Canada site licensing, TGA (Australia) listing, and NSF International certification, though NSF could not be confirmed through NSF's public GMP directory as of March 2026. Gemini was the first manufacturer to earn RIBUS Certified Contract Manufacturer status for clean label products. They recently received approval for a $25 million expansion supported by Suffolk County IDA incentives. This expansion includes a new probiotic supplement facility at 81 Modular Avenue. Their 300,000 unit minimum order signals they serve mid-to-large brands, not startups. The ISO 17025 accredited in-house laboratory handles identity testing, potency analysis, and stability studies.

Commack, New York

Directory Listing · Records Reviewed

Public records and independent sources have been reviewed.

What this means →
MOQ
300,000 units
LEAD TIME
Not publicly disclosed
Request a free introWhy we recommend this vendor · read the rationale

§1Editorial assessment

Gemini Pharmaceuticals has produced tablets, capsules, and OTC pharmaceuticals from Commack, New York for over 30 years. The company produces 13 billion dosage units per year and packages over 150,000 bottles per shift. They report FDA registration, Health Canada site licensing, TGA (Australia) listing, and NSF International certification, though NSF could not be confirmed through NSF's public GMP directory as of March 2026. Gemini was the first manufacturer to earn RIBUS Certified Contract Manufacturer status for clean label products. They recently received approval for a $25 million expansion supported by Suffolk County IDA incentives. This expansion includes a new probiotic supplement facility at 81 Modular Avenue. Their 300,000 unit minimum order signals they serve mid-to-large brands, not startups. The ISO 17025 accredited in-house laboratory handles identity testing, potency analysis, and stability studies.

§2Six-gate readout

Six gates we apply before any name appears in the directory. Each gate is auto-derived from public evidence on this profile.

Evidence: warn.
Provenance: miss.
Disclosure: pass.
Freshness: pass.
Challenge: pass.
Abstention: miss.

§3Inspection history

§4Certifications

0 of 8 certifications independently confirmed. What this means

§5Capability matrix

PRODUCT TYPES
Tablets · Capsules · OTC Pharmaceuticals
CAPABILITIES
Contract Manufacturing · Private Label · In-House Testing Lab · Clean Label Products · OTC Pharmaceuticals
DOSAGE FORMS
capsules · tablets

§6Sources

Dietary supplement manufacturers must comply with 21 CFR Part 111 (Current Good Manufacturing Practice for dietary supplements). This includes requirements for personnel, facilities, equipment, production, laboratory operations, and record-keeping.

Disclosures

  • No material connection exists between Inventory Ready and this manufacturer

Interested in Gemini Pharmaceuticals?

Tell us about your project and we'll help you determine if this manufacturer is a good fit.

Educational information only. Not legal, regulatory, or professional advice. Inventory Ready provides independent assessments based on publicly available information. See Terms for details.